FDA Town Hall

10:45 AM - 11:30 AM (EDT), Tuesday, June 6, 2023 ・ Session Room 205ABC
Join us for a hybrid discussion with the directors of the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA). Topics will include center priorities, staffing, and navigating changes from the COVID-19 pandemic.
Moderator
Chairman and Chief Executive Officer
Alkermes, Inc.
Speakers
Director, Center for Biologics Evaluation and Research (CBER)
U.S. Food and Drug Administration
Director, Center for Drug Evaluation and Research
FDA